Showing results (81-90 of 243) with videos related to
Sort By:
Pageof 25
Journal of Proteome Research|January 15, 2025
IP-to-MS: An Unbiased Workflow for Antigen ProfilingStephanie Biedka, Svitlana Yablonska, Xi Peng, et al.Arthritis and Rheumatism|May 2, 2007
Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosusChin Lee, Orit Almagor, Dorothy D Dunlop, et al.Annals of Human Genetics|September 29, 2007
Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activityDharambir K Sanghera, Susan Manzi, Ryan L Minster, et al.Arthritis and Rheumatism|October 4, 2005
Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosusChau-Ching Liu, Susan Manzi, Amy H Kao, et al.Arthritis Care & Research|September 16, 2025
Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual CareTarun Sharma, Tyson S Barrett, Teigan Dwyer, et al.Arthritis Care & Research|December 17, 2019
Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic SclerosisMichael Hughes, John D Pauling, Jennifer Jones, et al.Clinical and Experimental Rheumatology|August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationaleDinesh Khanna, Christopher P Denton, Shervin Assassi, et al.The Journal of Rheumatology|March 17, 2017
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis CohortJessica K Gordon, Gandikota Girish, Veronica J Berrocal, et al.ACR Open Rheumatology|February 2, 2023
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic SclerosisRobyn T Domsic, Robin Pokrzywinski, Larissa Stassek, et al.Clinical and Translational Science|February 18, 2010
Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosusChau-Ching Liu, Amy H Kao, Douglas M Hawkins, et al.Pageof 25